Search
Prothipendyl
go.drugbank.com/drugs/DB12958InvestigationalProthipendyl has been used in trials studying the treatment of Dementia, Depression, Schizophrenia, Anxiety Disorders, and Psychosomatic Disorders.
Products: DOMINAL 40MG UTACeftazidime
go.drugbank.com/drugs/DB00438ApprovedInvestigationalBacteria possess a cell wall comprising a glycopeptide polymer commonly known as peptidoglycan, which is synthesized and remodelled through the action of a family of enzymes known as "penicillin-binding proteins" (PBPs). β-lactam antibio...
Mixtures: CEFAZIME FOR INJECTION 1 g/vialCategories: Antibacterials for Systemic Use, Antiinfectives for Systemic UseBarium sulfate
go.drugbank.com/drugs/DB11150ApprovedBarium sulfate is ingested by mouth or administered rectally and combined with granules of effervescent bicarbonate to enhance distension of the GI tract, allowing for enhanced gastrointestinal tract visualization
Products: Baricon for Suspension, Barosperse for Susp 95%Bivalirudin
go.drugbank.com/drugs/DB00006ApprovedInvestigationalBivalirudin is a synthetic 20 residue peptide (thrombin inhibitor) which reversibly inhibits thrombin. Once bound to the active site, thrombin cannot activate fibrinogen into fibrin, the crucial step in the formation of thrombus. It is a...
Products: Bivalirudin for Injection, Bivalirudin Accord 250 mg Pulver für ein Konzentrat zur Herstellung einer Injektions-/InfusionslösungFibrinogen human
go.drugbank.com/drugs/DB09222ApprovedInvestigationalIt is a soluble plasma glycoprotein with a molecular weight of about 340 kDa and is a physiological substrate for three enzymes: plasmin, factor XIIIa, and thrombin. … It is indicated for the treatment of acute bleeding episodes in patients with both acquired and congenital fibrinogen deficiency, including afibrinogenemia and hypofibrinogenemia.[L41065]
Mixtures: ARTISS SOLUTIONS FOR SEALANT, DEEP FROZEN, ARTISS - Lösungen für einen GewebekleberProducts: HAEMOCOMPLETTAN P POWDER FOR SOLUTION FOR INJECTION OR INFUSION 1G/VIAL, Fibryga 1g Powder and Solvent for Solution for Injection or InfusionCoagulation Factor IX Human
go.drugbank.com/drugs/DB13152ApprovedInvestigationalFactor IX (or Christmas factor) is one of the serine proteases of the coagulation system; it belongs to peptidase family S1. Deficiency of this protein causes hemophilia B.
Mixtures: UMAN COMPLEX, UMAN COMPLEXProducts: IMMUNINE 120IU/ML Powder and solvent for solution for injection or infusion, REPLENINE-VF 500 FOR INJECTIONCefaclor
go.drugbank.com/drugs/DB00833ApprovedInvestigationalSemisynthetic, broad-spectrum antibiotic derivative of cephalexin.
Categories: Antibacterials for Systemic Use, Antiinfectives for Systemic UseProducts: SOFICLOR FOR ORAL SUSPENSION 125 mg/5 ml, VERCEF GRANULES FOR RECONSTITUTION 187 mg/5 mlAntihemophilic factor human
go.drugbank.com/drugs/DB13192ApprovedInvestigationalAntihemophilic factor human is approved by the Food and Drug Administration for use in hemophilia A (classical hemophilia) for the prevention and control of hemorrhagic episodes [FDA Label]. … Exogenous replacement of Factor VIII is currently the cornerstone of Hemophilia treatment and is used for the prophylaxis and control of bleeding episodes.
Mixtures: Haemate P Powder and solvent for solution for injection or infusion, Wilate 500, 500 IU VWF/500 IU FVIII, Powder and Solvent for Solution for InjectionProducts: NUWIQ POWDER AND SOLVENT FOR SOLUTION FOR INJECTION 500 IU, NUWIQ POWDER AND SOLVENT FOR SOLUTION FOR INJECTION 250 IUNipocalimab
go.drugbank.com/drugs/DB16257ApprovedInvestigational[L64043,L64045] On August 24, 2026, the FDA approved it for warm autoimmune hemolytic anemia (wAIHA), making it the first therapy approved for that condition.[L64043,L64044,L64045] … [L64042] Nipocalimab-aahu was first approved by the FDA in April 2025 for generalized myasthenia gravis.
Categories: Neonatal Fc Receptor BlockerSynonyms: immunoglobulin G1-lambda, anti-[Homo sapiens FCGRT (Fc fragment of IgG receptor and transporter, neonatal Fc receptor, FcRn, transmembrane alpha chain of the neonatal receptor)], Homo sapiens monoclonal, Immunoglobulin g1, anti-(human neonatal fc receptor) (human monoclonal m281 .gamma.-1 chain), disulfide with human monoclonal m281 .lambda.-chain, dimerBotulinum toxin type A
go.drugbank.com/drugs/DB00083ApprovedInvestigational[A231819,L32569] A popular use for Botox is the treatment of facial wrinkles and lines, however, there are many uses for the botulinum toxin A in the treatment of dystonia, incontinence, migraine, blepharospasm … In 2002, botulinum toxin A, also known as onabotulinumtoxinA or Botox, was the first type A botulism toxin to be introduced into the market for cosmetic use.
Products: XEOMIN powder for solution for injection 100 LD50 units, Neuronox ® Powder for Solution for Injection 100 units